VYOME HOLDINGS, INC. Deferred Income Tax Expense (Benefit)
VYOME HOLDINGS, INC. (HIND) reported Deferred Income Tax Expense (Benefit) of -$6.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2025-08-14
- VYOME HOLDINGS, INC. deferred income tax expense (benefit) for the quarter ending 2025-06-30 was -$2.00K.
- VYOME HOLDINGS, INC. deferred income tax expense (benefit) for the quarter ending 2025-03-31 was -$4.00K, a 500.00% decline year-over-year.
- VYOME HOLDINGS, INC. deferred income tax expense (benefit) for the quarter ending 2024-06-30 was $0.00.
- VYOME HOLDINGS, INC. deferred income tax expense (benefit) for the quarter ending 2024-03-31 was $1.00K.
- VYOME HOLDINGS, INC. deferred income tax expense (benefit) for fiscal 2024 was $6.00K, a 78.57% decline from fiscal 2023.
- VYOME HOLDINGS, INC. deferred income tax expense (benefit) for fiscal 2023 was $28.00K.
- VYOME HOLDINGS, INC. deferred income tax expense (benefit) for fiscal 2022 was -$423.00K.
- VYOME HOLDINGS, INC. deferred income tax expense (benefit) for fiscal 2021 was -$248.00K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 9 month as first filed | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$6.00K 10-Q · filed 2025-08-14 | ||||
| 2025-03-31 | -$4.00K 10-Q · filed 2025-05-20 | |||||
| 2024-12-31 | $6.00K 10-K · filed 2025-04-04 | |||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.00K 10-Q · filed 2025-08-14 | $28.00K derived: sum of 3 quarters · filed 2025-08-14 | $30.00K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $1.00K 10-Q · filed 2025-05-20 | $28.00K derived: sum of 2 quarters · filed 2025-05-20 | $30.00K derived: sum of 3 quarters · filed 2025-05-20 | $30.00K derived: sum of 4 quarters · filed 2025-05-20 | ||
| 2023-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $29.00K derived: sum of 2 quarters · filed 2025-04-04 | $29.00K derived: sum of 3 quarters · filed 2025-04-04 | $28.00K 10-K · filed 2025-04-04 | ||
| 2023-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $2.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.00K 10-Q · filed 2024-11-14 | -$54.00K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$1.00K 10-Q · filed 2024-08-14 | -$56.00K derived: sum of 3 quarters · filed 2024-08-14 | -$236.00K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | -$1.00K 10-Q · filed 2024-05-15 | -$56.00K derived: sum of 2 quarters · filed 2024-05-15 | -$236.00K derived: sum of 3 quarters · filed 2024-05-15 | -$237.00K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | -$55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$235.00K derived: sum of 2 quarters · filed 2024-04-01 | -$236.00K derived: sum of 3 quarters · filed 2024-04-01 | -$423.00K 10-K · filed 2024-04-01 | ||
| 2022-09-30 | -$180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$181.00K derived: sum of 2 quarters · filed 2023-11-09 | -$368.00K 10-Q · filed 2023-11-09 | -$555.00K 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | -$188.00K 10-Q · filed 2022-08-19 | ||||
| 2022-03-31 | -$187.00K 10-Q · filed 2022-05-23 | |||||
| 2021-12-31 | -$248.00K 10-K · filed 2023-04-17 | -$60.00K 10-K · filed 2022-04-08 | ||||
| 2020-12-31 | -$86.00K 10-K · filed 2022-04-08 | $0.00 10-K · filed 2021-03-12 | ||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-12 | |||||
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 | |||||
| 2017-12-31 | $0.00 10-K · filed 2019-02-22 | |||||
| 2016-12-31 | $0.00 10-K · filed 2018-03-05 | |||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-05 | |||||
| 2014-12-31 | $0.00 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |